We recently published an article titled Top 10 Health Information Services Stocks Outpacing The Market In 2025. In this article, we are going to take a look at where Privia Health Group, Inc. (NASDAQ:PRVA) stands against the other health information services stocks.
Health Information Services stocks have become a key focus for investors as AI starts to enter more domains in 2025. Some of the most amazing gains have come in health information services stocks that are utilizing AI to improve research and services in the healthcare sector.
The healthcare information services sector allows investors to gain exposure to a number of growing and emerging technologies including cloud-backed software solutions to physician enablement platforms. Some of the companies in our list are surging based on earnings anticipation while others are increasing in share price because of their upcoming products or revenue growth.
To come up with our list of top 10 health information services stocks outpacing the broader market in 2025, we only considered stocks with a market cap of at least $2 billion that were outperforming the S&P 500 index.
A physician leveraging innovative technology to enable their patient care decisions.
Privia Health Group, Inc. (NASDAQ:PRVA)
Privia Health Group, Inc. is a physician enablement company that joins forces with health plans, medical groups, and health systems. The company provides technology and population health tools to improve networks for purchasers and payers, independent providers’ workflows, management services organization, and other processes. Its stock is up 27% this year.
Privia Health Group, Inc. is another relatively unknown healthcare stock that is gaining in 2025. It boasts a strong balance sheet with more than a third of its assets in cash and cash equivalents and almost no long-term debt. That’s because it runs on an asset-light model that also helps it keep healthy cash flows.
However, on the earnings front, the company leaves a lot to be desired. Its revenue growth has been declining since June 2022 with revenues stagnating in the last 6 quarters. Unless the company fixes that, even a good earnings report later this month may only bring a temporary rally in the stock if it hasn’t already priced that in.
READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap
This article was originally published at Insider Monkey.
Hedge Fund Resource Center